NL7107529A - - Google Patents

Info

Publication number
NL7107529A
NL7107529A NL7107529A NL7107529A NL7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A
Authority
NL
Netherlands
Application number
NL7107529A
Other versions
NL177599B (nl
NL177599C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7107529A publication Critical patent/NL7107529A/xx
Publication of NL177599B publication Critical patent/NL177599B/xx
Application granted granted Critical
Publication of NL177599C publication Critical patent/NL177599C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7107529A 1970-06-02 1971-06-01 Werkwijze voor het winnen en zuiveren van immunoglobuline g. NL177599C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (enExample) 1970-06-02 1970-06-02

Publications (3)

Publication Number Publication Date
NL7107529A true NL7107529A (enExample) 1971-12-06
NL177599B NL177599B (nl) 1985-05-17
NL177599C NL177599C (nl) 1985-10-16

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7107529A NL177599C (nl) 1970-06-02 1971-06-01 Werkwijze voor het winnen en zuiveren van immunoglobuline g.

Country Status (8)

Country Link
AT (1) AT309678B (enExample)
CA (1) CA960964A (enExample)
CH (1) CH572745A5 (enExample)
DE (1) DE2127159C2 (enExample)
FR (1) FR2100716B1 (enExample)
GB (1) GB1344340A (enExample)
NL (1) NL177599C (enExample)
SE (1) SE348942B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
CN102272146A (zh) * 2009-01-13 2011-12-07 通用电气健康护理生物科学股份公司 用带负电的聚合物沉淀生物分子
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
CA2846599A1 (en) 2011-08-26 2013-03-07 Baxter International Inc. Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之i-iv-1部分沉澱
FI3590960T3 (fi) 2012-02-29 2023-04-25 Takeda Pharmaceuticals Co Perifeeristen hermojen IgG-stimuloitu remyelinaatio
WO2014134070A1 (en) 2013-02-26 2014-09-04 Baxter International Inc. Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
HUE044737T2 (hu) 2013-05-06 2019-11-28 Baxalta Inc Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel
US20250188120A1 (en) 2022-03-07 2025-06-12 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (enExample) * 1962-01-03
BE713764A (enExample) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Also Published As

Publication number Publication date
FR2100716A1 (enExample) 1972-03-24
DE2127159C2 (de) 1981-12-24
AT309678B (de) 1973-08-27
NL177599B (nl) 1985-05-17
SE348942B (enExample) 1972-09-18
CA960964A (en) 1975-01-14
CH572745A5 (enExample) 1976-02-27
DE2127159A1 (de) 1971-12-09
FR2100716B1 (enExample) 1975-06-06
GB1344340A (en) 1974-01-23
NL177599C (nl) 1985-10-16

Similar Documents

Publication Publication Date Title
FR2076103B1 (enExample)
FR2083614A1 (enExample)
FR2076125A1 (enExample)
FR2100716B1 (enExample)
FR2089417A5 (enExample)
FR2084135A5 (enExample)
FR2083789A5 (enExample)
FR2084901A5 (enExample)
FR2081940B1 (enExample)
FI49944B (enExample)
DE2046276B2 (enExample)
FR2083921A5 (enExample)
FR2083938A5 (enExample)
FR2084370A5 (enExample)
FR2079232A1 (enExample)
DE2122505B2 (enExample)
FR2075943B1 (enExample)
FR2083613A1 (enExample)
FR2074698B1 (enExample)
FR2076618A5 (enExample)
FR2084897A5 (enExample)
CS166353B1 (enExample)
FR2081437A1 (enExample)
FR2083827A5 (enExample)
FR2059848A5 (enExample)

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maxim lifetime of a patent